Literature DB >> 24781087

Homozygous truncating PTPRF mutation causes athelia.

Guntram Borck1, Liat de Vries, Hsin-Jung Wu, Pola Smirin-Yosef, Gudrun Nürnberg, Irina Lagovsky, Luis Henrique Ishida, Patrick Thierry, Dagmar Wieczorek, Peter Nürnberg, John Foley, Christian Kubisch, Lina Basel-Vanagaite.   

Abstract

Athelia is a very rare entity that is defined by the absence of the nipple-areola complex. It can affect either sex and is mostly part of syndromes including other congenital or ectodermal anomalies, such as limb-mammary syndrome, scalp-ear-nipple syndrome, or ectodermal dysplasias. Here, we report on three children from two branches of an extended consanguineous Israeli Arab family, a girl and two boys, who presented with a spectrum of nipple anomalies ranging from unilateral hypothelia to bilateral athelia but no other consistently associated anomalies except a characteristic eyebrow shape. Using homozygosity mapping after single nucleotide polymorphism (SNP) array genotyping and candidate gene sequencing we identified a homozygous frameshift mutation in PTPRF as the likely cause of nipple anomalies in this family. PTPRF encodes a receptor-type protein phosphatase that localizes to adherens junctions and may be involved in the regulation of epithelial cell-cell contacts, peptide growth factor signaling, and the canonical Wnt pathway. Together with previous reports on female mutant Ptprf mice, which have a lactation defect, and disruption of one allele of PTPRF by a balanced translocation in a woman with amastia, our results indicate a key role for PTPRF in the development of the nipple-areola region.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24781087     DOI: 10.1007/s00439-014-1445-1

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  31 in total

1.  Contact inhibition of hepatocyte growth regulated by functional association of the c-Met/hepatocyte growth factor receptor and LAR protein-tyrosine phosphatase.

Authors:  Mitsuru Machide; Atsuko Hashigasako; Kunio Matsumoto; Toshikazu Nakamura
Journal:  J Biol Chem       Date:  2006-01-16       Impact factor: 5.157

2.  Specific inhibition of FGF-induced MAPK activation by the receptor-like protein tyrosine phosphatase LAR.

Authors:  X Wang; L P Weng; Q Yu
Journal:  Oncogene       Date:  2000-05-04       Impact factor: 9.867

3.  Dominant inheritance of absence of the breast.

Authors:  M G Wilson; E B Hall; A J Ebbin
Journal:  Humangenetik       Date:  1972

4.  Complete breast absence in siblings.

Authors:  M Kowlessar; E Orti
Journal:  Am J Dis Child       Date:  1968-01

5.  Loss-of-function mutations of ILDR1 cause autosomal-recessive hearing impairment DFNB42.

Authors:  Guntram Borck; Atteeq Ur Rehman; Kwanghyuk Lee; Hans-Martin Pogoda; Naseebullah Kakar; Simon von Ameln; Nicolas Grillet; Michael S Hildebrand; Zubair M Ahmed; Gudrun Nürnberg; Muhammad Ansar; Sulman Basit; Qamar Javed; Robert J Morell; Nabilah Nasreen; A Eliot Shearer; Adeel Ahmad; Kimia Kahrizi; Rehan S Shaikh; Rana A Ali; Shaheen N Khan; Ingrid Goebel; Nicole C Meyer; William J Kimberling; Jennifer A Webster; Dietrich A Stephan; Martin R Schiller; Melanie Bahlo; Hossein Najmabadi; Peter G Gillespie; Peter Nürnberg; Bernd Wollnik; Saima Riazuddin; Richard J H Smith; Wasim Ahmad; Ulrich Müller; Matthias Hammerschmidt; Thomas B Friedman; Sheikh Riazuddin; Suzanne M Leal; Jamil Ahmad; Christian Kubisch
Journal:  Am J Hum Genet       Date:  2011-01-20       Impact factor: 11.025

Review 6.  The Wnt/β-catenin signaling pathway: a potential therapeutic target in the treatment of triple negative breast cancer.

Authors:  Taj D King; Mark J Suto; Yonghe Li
Journal:  J Cell Biochem       Date:  2012-01       Impact factor: 4.429

7.  PTPRF is disrupted in a patient with syndromic amastia.

Authors:  Surasawadee Ausavarat; Siraprapa Tongkobpetch; Verayuth Praphanphoj; Charan Mahatumarat; Nond Rojvachiranonda; Thiti Snabboon; Thomas C Markello; William A Gahl; Kanya Suphapeetiporn; Vorasuk Shotelersuk
Journal:  BMC Med Genet       Date:  2011-03-31       Impact factor: 2.103

8.  Inactivation of LAR family phosphatase genes Ptprs and Ptprf causes craniofacial malformations resembling Pierre-Robin sequence.

Authors:  Katherine Stewart; Noriko Uetani; Wiljan Hendriks; Michel L Tremblay; Maxime Bouchard
Journal:  Development       Date:  2013-07-17       Impact factor: 6.868

9.  Regulation of adipogenic differentiation by LAR tyrosine phosphatase in human mesenchymal stem cells and 3T3-L1 preadipocytes.

Authors:  Won-Kon Kim; Hyeyun Jung; Do-Hyung Kim; Eun-Young Kim; Jin-Woong Chung; Yee-Sook Cho; Sung-Goo Park; Byoung-Chul Park; Yong Ko; Kwang-Hee Bae; Sang-Chul Lee
Journal:  J Cell Sci       Date:  2009-11-15       Impact factor: 5.285

10.  The C. elegans LAR-like receptor tyrosine phosphatase PTP-3 and the VAB-1 Eph receptor tyrosine kinase have partly redundant functions in morphogenesis.

Authors:  Robert J Harrington; Michael J Gutch; Michael O Hengartner; Nicholas K Tonks; Andrew D Chisholm
Journal:  Development       Date:  2002-05       Impact factor: 6.868

View more
  2 in total

1.  Phenotypic expansion of KMT2D-related disorder: Beyond Kabuki syndrome.

Authors:  Dustin Baldridge; Rebecca C Spillmann; Daniel J Wegner; Jennifer A Wambach; Frances V White; Kathleen Sisco; Tomi L Toler; Patricia I Dickson; F Sessions Cole; Vandana Shashi; Dorothy K Grange
Journal:  Am J Med Genet A       Date:  2020-02-21       Impact factor: 2.802

2.  A patient with van Maldergem syndrome with endocrine abnormalities, hypogonadotropic hypogonadism, and breast aplasia/hypoplasia.

Authors:  Juan Sotos; Katherine Miller; Donald Corsmeier; Naomi Tokar; Benjamin Kelly; Vijay Nadella; Huachun Zhong; Amy Wetzel; Brent Adler; Chack-Yung Yu; Peter White
Journal:  Int J Pediatr Endocrinol       Date:  2017-10-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.